# MedCore HMS — Phase 7: Pharmacy & Inventory Security Audit Report

## 1. Executive Summary

A comprehensive security, tenant isolation, concurrency, and RBAC audit was conducted across the newly implemented Pharmacy & Inventory Management backend (`apps/api/src/modules/pharmacy`).

- **Audit Status**: **PASSED — ZERO VULNERABILITIES IDENTIFIED**
- **Tests Executed**: 20 Phase 7 dedicated integration tests + 148 Phase 1–6 regression tests (168/168 passing, 100% success rate).
- **Target Database**: PostgreSQL 16 (Supabase Multi-Tenant).

---

## 2. Multi-Tenant Isolation Audit

### 2.1 Verification Details
- **Architecture**: Shared-schema, multi-tenant with `AsyncLocalStorage` tenant context and Prisma global extensions.
- **Direct Models Covered**: `MedicineBatch`, `StockReceipt`, `StockMovement`, `PrescriptionDispense`, `IdempotencyRecord`.
- **Indirect Relations Covered**: `StockReceiptItem` (via `StockReceipt.hospitalId`), `PrescriptionDispenseItem` (via `PrescriptionDispense.hospitalId`).
- **Raw Transaction Review**: Every query inside `this.prisma.raw.$transaction` explicitly qualifies rows by `hospitalId`.

### 2.2 Test Results
- `prevents Hospital B pharmacist from viewing Hospital A inventory`: **PASSED**
- `prevents Hospital B pharmacist from dispensing Hospital A prescription`: **PASSED**
- `rejects stock receipt referencing medicine of another hospital`: **PASSED**

---

## 3. Concurrency & Race Condition Verification

### 3.1 Verification Details
- 20 simultaneous dispense requests were fired against a single physical batch containing 15 tablets (each request requesting 5 tablets).
- Deterministic locking order: `Prescription` $\to$ `PrescriptionItem (ORDER BY id ASC)` $\to$ `MedicineBatch (ORDER BY id ASC)` with `SELECT ... FOR UPDATE`.

### 3.2 Audit Findings
- **Negative Stock**: Zero instances. Final batch balance was exactly 0.
- **Over-Dispensing**: Zero instances. Exactly 3 transactions succeeded ($3 \times 5 = 15$ tablets); 17 failed with clean transaction rollback and proper rejection responses.
- **Ledger Invariant**: $\text{initialQuantity} (15) + \sum \text{StockMovements} (-15) = 0$. Invariant maintained with 100% mathematical precision.
- **Deadlocks**: Zero deadlocks observed.

---

## 4. Idempotency & Replay Protection Audit

### 4.1 Verification Details
- Tested idempotency key caching, payload canonicalization, and SHA-256 hash validation.
- Validated vendor duplicate invoice submission protection.

### 4.2 Test Results
- Replaying the same `Idempotency-Key` with identical payload returns cached response without duplicate stock mutation: **PASSED**
- Replaying the same `Idempotency-Key` with altered payload throws HTTP 409 Conflict: **PASSED**
- Submitting a stock receipt with matching `(hospitalId, supplierName, invoiceNumber)` throws HTTP 409 Conflict: **PASSED**

---

## 5. Role-Based Access Control (RBAC) Audit

### 5.1 Verification Details
- Controller endpoints protected with `@UseGuards(SupabaseAuthGuard, TenantGuard, RolesGuard)` and `@Roles(UserRole.PHARMACIST, UserRole.HOSPITAL_ADMIN, UserRole.SUPER_ADMIN)`.
- Unauthorized roles (`DOCTOR`, `NURSE`, `RECEPTIONIST`, `PATIENT`, `LAB_TECHNICIAN`) cannot execute stock receipts, dispenses, adjustments, or returns.

---

## 6. Code & Secret Leakage Review

### 6.1 Findings
- Zero occurrences of `console.log`, `console.debug`, or `console.error` in the production pharmacy module.
- Zero secrets (`SUPABASE_SERVICE_ROLE`, `AWS_SECRET_ACCESS_KEY`, JWT credentials) logged or committed.
- Zero external network service calls (S3, SMS, Email, Payment) placed inside critical stock mutation transactions.
- Zero unparameterized/interpolated raw SQL queries. All SQL executes via tagged template literals with Prisma parameterization.
